Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recovery
Researchers at Egypt's National Research Centre report a novel coumarin‑pyrazoline‑indolinone compound (CPPI) that exhibited antimicrobial activity against MRSA, Bacillus cereus and Pseudomonas, enhanced fibroblast migration, accelerated wound closure and complete re-epithelialization in vitro and in vivo, and showed COX-2 binding in docking and molecular dynamics studies.
Why it mattersMRSA-active CPPI with COX-2 affinity indicates prioritizing preclinical development of antimicrobial wound dressings.